Immunohistochemistry in tissue samples showed the expression of NCOA1, NCOA2, NCOA3, CREBBP, and EP300, in 85%–100% of bladder tumors—some of which even lacked AR expression [35]. This evidence concerns the gene AR and urinary bladder neoplasm.